Wells Fargo & Company X Biotech Inc. Transaction History
Wells Fargo & Company
- $410 Billion
- Q1 2024
A detailed history of Wells Fargo & Company transactions in X Biotech Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 155 shares of XBIT stock, worth $925. This represents 0.0% of its overall portfolio holdings.
Number of Shares
155
Previous 152
1.97%
Holding current value
$925
Previous $0
Infinity%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding XBIT
# of Institutions
47Shares Held
3.96MCall Options Held
6.3KPut Options Held
1.7K-
Israel Englander Millennium Management LLC | New York, Ny927KShares$5.54 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA895KShares$5.35 Million0.0% of portfolio
-
Black Rock Inc. New York, NY307KShares$1.83 Million0.0% of portfolio
-
Credit Suisse Ag Zurich, V8248KShares$1.48 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA195KShares$1.17 Million0.0% of portfolio
About XBiotech Inc.
- Ticker XBIT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,439,300
- Market Cap $182M
- Description
- XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical...